Approval · Notice of Compliance 28370 · 2022
NITISINONE TABLETS: Notice of Compliance 28370
Issued June 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28370
- Date
- June 9, 2022
- Company
- Cycle Pharmaceuticals LtdCambridge, Cambridgeshire, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the Product Monograph to the 2020 format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NITISINONE TABLETS | Not yet assigned | — |
Medicinal ingredients
- NITISINONE 2 MG per TAB
- NITISINONE 5 MG per TAB
- NITISINONE 10 MG per TAB